TY - JOUR
T1 - Interdependent genotoxic mechanisms of monomethylarsonous acid
T2 - Role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells
AU - Wnek, Shawn M.
AU - Kuhlman, Christopher L.
AU - Camarillo, Jeannie M.
AU - Medeiros, Matthew K.
AU - Liu, Ke J.
AU - Lau, Serrine S.
AU - Gandolfi, A. J.
N1 - Funding Information:
Supported by NIEHS grants ES04940, ES06694, and ES07091.
Funding Information:
The authors would like to thank Drs. Donald and Mary Ann Sens and Dr. Scott Garret for the UROtsa cells and assistance with culturing conditions, Dr. Joceline Lega (Department of Mathematics, University of Arizona) for the comet analysis software, Doug Cromey (SWEHS Imaging Core Facility) for his help with image analysis, Mike Kopplin for ICP-MS analysis (UA SRBP), and the Synthetic Chemistry Facility Core (Southwest Environmental Health Sciences Center, Tucson, AZ) for the Diiodomethylarsine (MMA III ). The authors would also like to thank Daniel Troup and Tam Mihn Le for performing the MMA III /zinc solubility studies. The research herein was made possible by the NIEHS Superfund Basic Research Program ( ES 04940 ) and the Southwest Environmental Health Sciences Center ( ES 06694 ). SMW is funded by the NIEHS SRP UA Training Core and NIEHS Training Grant ( ES 07091 ). The authors declare no Conflict of Interests.
PY - 2011/11/15
Y1 - 2011/11/15
N2 - Exposure of human bladder urothelial cells (UROtsa) to 50nM of the arsenic metabolite, monomethylarsonous acid (MMAIII), for 12weeks results in irreversible malignant transformation. The ability of continuous, low-level MMAIII exposure to cause an increase in genotoxic potential by inhibiting repair processes necessary to maintain genomic stability is unknown. Following genomic insult within cellular systems poly(ADP-ribose) polymerase-1 (PARP-1), a zinc finger protein, is rapidly activated and recruited to sites of DNA strand breaks. When UROtsa cells are continuously exposed to 50nM MMAIII, PARP-1 activity does not increase despite the increase in MMAIII-induced DNA single-strand breaks through 12weeks of exposure. When UROtsa cells are removed from continuous MMAIII exposure (2weeks), PARP-1 activity increases coinciding with a subsequent decrease in DNA damage levels. Paradoxically, PARP-1 mRNA expression and protein levels are elevated in the presence of continuous MMAIII indicating a possible mechanism to compensate for the inhibition of PARP-1 activity in the presence of MMAIII. The zinc finger domains of PARP-1 contain vicinal sulfhydryl groups which may act as a potential site for MMAIII to bind, displace zinc ion, and render PARP-1 inactive. Mass spectrometry analysis demonstrates the ability of MMAIII to bind a synthetic peptide representing the zinc-finger domain of PARP-1, and displace zinc from the peptide in a dose-dependent manner. In the presence of continuous MMAIII exposure, continuous 4-week zinc supplementation restored PARP-1 activity levels and reduced the genotoxicity associated with MMAIII. Zinc supplementation did not produce an overall increase in PARP-1 protein levels, decrease the levels of MMAIII-induced reactive oxygen species, or alter Cu-Zn superoxide dismutase levels. Overall, these results present two potential interdependent mechanisms in which MMAIII may increase the susceptibility of UROtsa cells to genotoxic insult and/or malignant transformation: elevated levels of MMAIII-induced DNA damage through the production of reactive oxygen species, and the direct MMAIII-induced inhibition of PARP-1.
AB - Exposure of human bladder urothelial cells (UROtsa) to 50nM of the arsenic metabolite, monomethylarsonous acid (MMAIII), for 12weeks results in irreversible malignant transformation. The ability of continuous, low-level MMAIII exposure to cause an increase in genotoxic potential by inhibiting repair processes necessary to maintain genomic stability is unknown. Following genomic insult within cellular systems poly(ADP-ribose) polymerase-1 (PARP-1), a zinc finger protein, is rapidly activated and recruited to sites of DNA strand breaks. When UROtsa cells are continuously exposed to 50nM MMAIII, PARP-1 activity does not increase despite the increase in MMAIII-induced DNA single-strand breaks through 12weeks of exposure. When UROtsa cells are removed from continuous MMAIII exposure (2weeks), PARP-1 activity increases coinciding with a subsequent decrease in DNA damage levels. Paradoxically, PARP-1 mRNA expression and protein levels are elevated in the presence of continuous MMAIII indicating a possible mechanism to compensate for the inhibition of PARP-1 activity in the presence of MMAIII. The zinc finger domains of PARP-1 contain vicinal sulfhydryl groups which may act as a potential site for MMAIII to bind, displace zinc ion, and render PARP-1 inactive. Mass spectrometry analysis demonstrates the ability of MMAIII to bind a synthetic peptide representing the zinc-finger domain of PARP-1, and displace zinc from the peptide in a dose-dependent manner. In the presence of continuous MMAIII exposure, continuous 4-week zinc supplementation restored PARP-1 activity levels and reduced the genotoxicity associated with MMAIII. Zinc supplementation did not produce an overall increase in PARP-1 protein levels, decrease the levels of MMAIII-induced reactive oxygen species, or alter Cu-Zn superoxide dismutase levels. Overall, these results present two potential interdependent mechanisms in which MMAIII may increase the susceptibility of UROtsa cells to genotoxic insult and/or malignant transformation: elevated levels of MMAIII-induced DNA damage through the production of reactive oxygen species, and the direct MMAIII-induced inhibition of PARP-1.
KW - Arsenic
KW - Bladder cancer
KW - Genotoxicity
KW - Monomethylarsonous acid
KW - Poly(ADP-ribose) polymerase-1
KW - UROtsa
UR - http://www.scopus.com/inward/record.url?scp=81255185302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81255185302&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2011.08.029
DO - 10.1016/j.taap.2011.08.029
M3 - Article
C2 - 21925530
AN - SCOPUS:81255185302
SN - 0041-008X
VL - 257
SP - 1
EP - 13
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 1
ER -